<ul><li><div><b>Isoniazid</b> is a(n)&nbsp;<u>`{{c1::inhibitor}}`</u> of <b>CYP-450</b></div><ul><li><div>Extra <br><paste-398766238597487.jpg" /></div></li></ul></li><li><div><u>`{{c1::Isoniazid</u> (INH)<u>}}`</u> can be used <i>alone</i> as treatment for <b>`{{c2::latent}}` tuberculosis</b> infections</div><ul><li><div><font color="#fc5a8d">Iso</font>niazid can be <font color="#fc5a8d">iso</font>lated as treatment<paste-54979876356566.jpg" /></div></li></ul></li><li><div><b>`{{c2::Isoniazid (INH)}}`</b> works by inhibiting the synthesis of **`{{c1::mycolic acid}}`** production on <i>`{{c1::Mycobacteria tuberculosis}}`</i></div><ul><li><div><i>found in the cell wall</i><i><paste-56285546414545.jpg" /></i></div></li></ul></li><li><div>Mutations in <i>Mycobacterium tuberculosis</i> that `{{c2::down}}`-regulate the expression of <u>KatG (a catalase-peroxidase)</u> lead to <b>`{{c1::Isoniazid::drug}}` resistance&nbsp;</b></div><ul><li><div><i>Isoniazid is activated by KatG, an enzyme produced by TB</i><br><paste-57101590200787.jpg"><br></div></li></ul></li><li><div>**`{{c1::Peripheral neuropathy}}`**, <b>ataxia</b>, and <b>paresthesias</b> are common side-effects of <b>`{{c2::Isoniazid}}`</b> therapy for <i>Mycobacterium tuberculosis</i></div><ul><li><div><i>Isoniazid leads to <font color="#fc5a8d">B<sub>6</sub> deficiency</font> -&gt; results in peripheral neuropathy</i><i><br></i><i><font color="#fc5a8d">INH</font> - <font color="#fc5a8d">i</font>njury to <font color="#fc5a8d">n</font>erves and <font color="#fc5a8d">h</font>epatocytes</i><i><br></i><i><paste-57281978827215.jpg"></i></div></li></ul></li><li><div><b>Isoniazid</b> is metabolized by the <u>hepatic enzyme</u> `{{c1::N-acetyltransferase}}`</div><ul><li><div><b>n-acetyltransferase 2 (NAT2)</b><paste-58914066399689.jpg"></div></li></ul></li><li><div>Slow-`{{c1::acetylators}}` have an increased risk of <u>side effects</u> from <b>Isoniazid (INH)</b></div><ul><li><div><i>will therefore have higher drug concentrations in blood, longer drug half-lives</i><i><br /></i><i>increased risk of <font color="#fc5a8d">peripheral neuropathy</font>!!</i><i><paste-58914066399689.jpg" /></i></div></li></ul></li><li><div><b>Isoniazid</b> promotes the excretion of `{{c1::pyridoxine (Vitamin B<sub>6</sub>)}}`, therefore resulting in <i>deficiency</i> and <u>peripheral neuropathy</u></div><ul><li><div><i>**coadministration of INH with B<sub>6</sub> can prevent peripheral neuropathy</i><i><paste-60056527700429.jpg" /></i></div></li></ul></li><li><div><b>Isoniazid</b> may also cause <u>altered mental status</u> and `{{c1::<u>seizures</u>}}` (CNS toxicity)</div><ul><li><div><paste-60898341290446.jpg" />**peripheral neuropathy is a PNS toxicity</div></li></ul></li><li><div><u>`{{c1::Hepato}}`-toxicity</u> is associated with <span style="font-weight: bold">Isoniazid</span> use</div><ul><li><div><i>recall that INH is hepatically metabolized (n-acetyltransferase)</i><i><br /></i><i>INH - injury to nerves and hepatocytes</i><i><br /></i><i><paste-61602715926989.jpg" /></i></div></li></ul></li><li><div><u>Isoniazid hepatotoxicity</u> results in an<i> asymptomatic</i> rise in `{{c1::aminotransferases (AST, ALT)}}` on LFTs</div><ul><li><div>Extra <br><paste-61795989455314.jpg" /></div></li></ul></li><li><div><u>Drug-induced `{{c1::lupus}}`</u> is an <i>immunologic</i> toxicity of <b>Isoniazid</b> use</div><ul><li><div>Extra <br><paste-61950608277975.jpg" /></div></li></ul></li><li><div><b>Isoniazid</b> use can result in <u>metabolic `{{c1::acidosis::acidosis or alkalosis}}`</u>&nbsp;</div><ul><li><div>Extra <br><paste-62053687493070.jpg" /></div></li></ul></li><li><div>The <b>metabolic acidosis</b> associated with <b>Isoniazid</b> use has a(n) <u>`{{c1::elevated::normal or elevated}}` anion gap</u>&nbsp;</div><ul><li><div>Extra <br><paste-62049392525774.jpg" /></div></li></ul></li><li><div><b>Isoniazid</b> `{{c1::inhibits::induces or inhibits}}` <u>cytochrome p450</u>&nbsp;</div><ul><li><div><i>can therefore <u>increase</u> concentration of drugs such as anti-epileptics and warfarin that use CYP450 for metabolism</i><i><paste-62328565400014.jpg" /></i></div></li></ul></li><li><div><b>Rifampin</b> `{{c1::induces::induces or inhibits}}` <u>cytochrome p450</u>&nbsp;</div><ul><li><div><i>can therefore <u>decrease</u> concentration of drugs such as anti-epileptics and warfarin that use CYP450 for metabolism</i><i><br /></i><i><font color="#fc5a8d">R</font>ifampin <font color="#fc5a8d">R</font>evs up CYP450</i><i><paste-63067299774926.jpg" /></i><i></i></div></li></ul></li><li><div><b>`{{c2::Rifampin::Antibacterial}}`</b> works by binding to bacterial <u>`{{c1::DNA-dependent RNA polymerase}}`</u>, <i>inhibiting</i> <b>RNA</b> synthesis</div><ul><li><div>Extra <br><paste-63230508532180.jpg" /></div></li></ul></li><li><div><b>Rifampin</b> is used as prophylactic <u>mono</u>-therapy in those exposed to `{{c1::<i>H. influenzae</i> and <i>Neisseria meningitidis</i>::what two bugs?}}`</div><ul><li><div>Extra <br><paste-64463164146124.jpg"><paste-64501818851792.jpg"><paste-64342905061839.jpg"><br></div></li></ul></li><li><div><b>Rifampin</b> use is associated with <u>`{{c1::hepato}}`-toxicity</u></div><ul><li><div><i>especially when used with other hepatotoxic drugs (RIPE therapy)</i><i><br /></i><i><paste-61602715926989.jpg" /></i></div></li></ul></li><li><div><b>`{{c2::Ethambutol}}`</b> blocks the enzyme **`{{c1::arabinosyl transferase}}`**, inhibiting <u>carbohydrate polymerization</u> at the bacterial cell wall</div><ul><li><div><font color="#66ccff">Arabian horse</font><paste-65455301591501.jpg"></div></li></ul></li><li><div><b>Pyrazinamide</b> is an antibiotic <u>only used</u> to treat <i>`{{c1::Mycobacterium tuberculosis}}`</i></div><ul><li><div><i><paste-65846143615439.jpg" /></i><i>as part of the RIPE therapy</i></div></li></ul></li><li><div>Which <u>RIPE</u> drug can cause&nbsp;<b>uric acid crystal</b> formation and ultimately <u><b>gout</b></u>?<br>`{{c1::Pyrazinamide}}`</div><ul><li><div>Extra <br><paste-65940632895952.jpg" /></div></li></ul></li><li><div><b>Pyrazinamide</b> is associated with <u>hyper-`{{c1::uricemia</u><u>}}`</u></div><ul><li><div><i>and therefore gout</i><i><paste-65936337928656.jpg" /></i></div></li></ul></li><li><div><b>Pyrazinamide</b> is `{{c1::hepato}}`-toxic, even leading to `{{c1::liver}}` necrosis</div><ul><li><div>Extra <br><paste-61602715926989.jpg" /></div></li></ul></li><li><div><b>Pyrazinamide</b> is a pro-drug that is converted into the active form, `{{c1::pyrazinoic acid}}`, by the enzyme <b>pyrazinamidase</b></div><ul><li><div>thus, resistance can occur with modification of pyrazinamidase</div></li></ul></li><li><div>**`{{c1::Pyrazinamide}}`** readily crosses the <u>blood-brain barrier</u>, and is used to treat <b>tuberculous meningitis</b></div><ul><li></li></ul></li><li><div>The <b>B<sub>6</sub> depletion</b> with <u>Isoniazid</u> use can lead to <i>decreased</i> `{{c1::protoporphyrin}}` <b>synthesis</b>, leading to a(n)&nbsp;<u>`{{c1::sideroblastic}}` anemia</u></div><ul><li><div>Extra <br><paste-333839217983923.jpg" /></div></li></ul></li><li><div><font color="#fc5a8d">Rifampin</font> can be remembered by the 4 R's<br>DNA-dependent <font color="#fc0280">R</font>NA polymerase inhibitor<br><font color="#fc0280">R</font>amps up microsomal CYP450<br><font color="#fc0280">R</font>ed/orange body fluids<br>Rapid `{{c4::<font color="#fc5a8d">R</font>esistance}}` if used alone</div><ul><li></li></ul></li><li><div><i>Mycobacterium `{{c1::avium complex</i><i>}}`</i> is a non-TB disease that causes <u>disseminated infection</u> in the late stages of <b>`{{c2::AIDS}}`</b></div><ul><li><div>Extra <br><paste-86870008529263.jpg" /></div></li></ul></li><li><div><i>Mycobacterium avium complex</i> includes <i>`{{c1::Mycobacterium avium}}` and </i><i>`{{c1::Mycobacterium intracellulare</i>}}`</div><ul><li><div>Extra <br><paste-85998130168180.jpg" /></div></li></ul></li><li><div><i>Mycobacterium avium complex</i> is treated with `{{c1::<u>azithromycin/clarithromycin</u> (a macrolide)}}` combined with `{{c2::<u>ethambutol</u>}}`</div><ul><li><div><i>***can also add <font color="#fc5a8d">rifabutin</font></i><paste-21272973017494.jpg" /><paste-86088324481393.jpg" /></div></li></ul></li><li><div>**`{{c2::Azithromycin}}`** prophylaxis for <i>Mycobacterium avium complex </i>should be started with <u>CD4+ counts</u> **`{{c1::&lt; 50}}`**</div><ul><li><div>Extra <br><paste-86990267613555.jpg" /><Xnip2018-03-89_13-48-54.jpg" /></div></li></ul></li><li><div>`{{c1::Rifabutin}}` may be added as a <u>third agent</u> in the treatment of <i>Mycobacterium avium complex</i></div><ul><li><div><i>***along with macrolides (azithromycin/clarithromycin) and ethambutol</i><i><paste-87677462380915.jpg" /></i></div></li></ul></li><li><div>Because <b>`{{c1::Rifabutin}}`</b> induces CYP450 <i>less</i> than other drugs in its class (i.e.&nbsp;Rifampin), it is used in the treatment of <u>`{{c2::tuberculosis}}`</u> in <b>`{{c2::HIV}}`</b> patients</div><ul><li><div>HIV drugs NRTIs are metabolized by CYP450, therefore the less aggressive induction of CYP450 doesn't counteract the dosing of NRTIs<br></div></li></ul></li><li><div>Side-effects of <u>Dapsone</u> include **`{{c1::agranulocytosis}}`** and **`{{c2::hemolytic anemia in G6PD deficiency}}`**</div><ul><li><div>Extra <br><paste-89481348645231.jpg"><paste-90310277333396.jpg"><paste-22604412879247.jpg"></div></li></ul></li><li><div><i>Mycobacteria `{{c1::marinum}}`</i> causes a <u>hand-infection</u> in <b>aquarium handlers</b></div><ul><li></li></ul></li><li><div><i>Mycobacteria `{{c1::scrofulaceum}}`</i> causes <b>cervical lymphadenitis</b> in <u>children</u></div><ul><li></li></ul></li><li><div>What drug can be used <i>instead</i> of <b>Ethambutol&nbsp;</b>to treat <i>Mycobacteria tuberculosis</i> infection?<br>`{{c1::Streptomycin}}`</div><ul><li></li></ul></li><li><div>Which etiology of <u>meningitis</u> is <b>Pyrazinamide</b> prescribed to treat?<br /><i>`{{c1::M. tuberculosis}}`</i></div><ul><li><div>readily crosses the blood-brain barrier</div></li></ul></li><li><div>Which <u>RIPE therapy</u> drug can cause <b>drug-induced lupus</b>?<br>`{{c1::Isoniazid}}`<br></div><ul><li><div>Extra <br><paste-61950608277975.jpg" /></div></li></ul></li><li><div><b>Rifamycins</b> can cause minor `{{c1::hepato}}`toxicity</div><ul><li><div>Remember, Rifabutin does NOT stimulate cyp450, while Rifampin DOES stimulate cyp450<br /><paste-365901148848129.jpg" /></div></li></ul></li><li><div>Which step (<font color="#aa0000"><b>[A] - [D]</b></font>) of Mycobacterial homeostasis does <b>Ethambutol</b> impact?<br /><span style="color: rgb(170, 0, 0)"><b>`{{c1::[D]}}`</b></span><span style="color: rgb(170, 0, 0); "><b><br /></b></span><img src="paste-737321330671617.jpg" /><br /></div><ul><li><div>Inhibits mycobacterial arabinosyl transferases which are part of the polymerization reaction of <b>arabinogalactan</b> (important part of the mycobacterial cell wall)<br /><paste-389648023027713.jpg" /><paste-375350076899329.jpg" /></div></li></ul></li><li><div>Is <b>Ethambutol</b> indicated to treat both tuberculous and nontuberculous mycobacteria?<br />`{{c1::Yes}}`</div><ul><li><div>- Tuberculosis- MAC infections (Ethambutol + Macrolide)</div></li></ul></li><li><div><b>Streptomycin</b> is a <u>second line</u> anti-tuberculosis drug that is a(n) `{{c1::aminoglycoside}}`</div><ul><li><div>Irreversibly binds the 30S ribosomal subunit and prevents formation of the <u>Initiation Complex</u><br><paste-815163317944321.jpg" class="resizer"><br><paste-404246616866817.jpg" class="resizer"></div></li></ul></li><li><div><b>Streptomycin</b> has notable `{{c1::CNS}}` toxicity and nephrotoxicity</div><ul><li><div>Can cause tinnitus, vertigo, ataxia</div></li></ul></li><li><div><b>Dapsone</b> is used to treat Mycobacterium **`{{c1::leprae}}`**</div><ul><li></li></ul></li><li><div><b>Pyrazinamide</b> is associated with side effects of <u>hepatotoxicity</u> and <u>hyper</u>`{{c1::<u>uric</u>}}`<u>emia</u></div><ul><li><div>- Organic ions (ex Pyrazinoate - metabolite of Pyrazinamide) counter-ion for uric acid at the URAT1 antiporter on the apical surface of the collecting duct<br />- thus the more Pyrazinamide secreted into the urine, more uric acid reabsorbed into the blood (same mechanism for Niacin ingestion and Lactate)<br /><paste-46312632352769.jpg" /><br /><br /><paste-348562365874177.jpg" /><paste-358853107515393.jpg" /><paste-365896853880833.jpg" /></div></li></ul></li><li><div><b>Streptomycin</b> can be also used to treat what zoonotic infection?<br />**`{{c1::Tularemia}}`**</div><ul><li><div>Extra <br><paste-367404387401729.jpg" /></div></li></ul></li><li><div>Treatment of tuberculosis with <b>isoniazid</b> can result in mycobacteria losing their "`{{c1::acid-fastness}}`", which will be visible on culture</div><ul><li><div>loss of mycolic acid synthesis prevents retention of acid fast dye</div></li></ul></li><li><div>Should you ever treat <b>active </b>tuberculosis with a monotherapy?<br />`{{c1::NO!}}`</div><ul><li><div>- Resistance develops rapidly due to "selective" gene mutations (Tb with gene mutations will survive, so monotherapy selects for those resistant types)<br />- thus treatment of active Tb is accomplished by combining multiple antibiotics to avoid selecting for resistant strains</div></li></ul></li></ul>